Risperdal fda approval date schizophrenia?

See the DrugPatentWatch profile for Risperdal

What was Risperdal’s FDA approval date for schizophrenia?

Risperdal (risperidone) was first approved by the FDA in 1993. However, the provided information here does not specify the exact FDA approval date for its specific indication of schizophrenia. [1]

When did Risperdal get approval specifically for schizophrenia?

FDA approvals are often granted for particular uses (indications), and those can be separate from the drug’s original approval date. To determine the exact schizophrenia-indication approval date, you need the FDA label history or the specific FDA approval record for the schizophrenia indication. The available source provided does not include that date. [1]

Where can I verify the exact “schizophrenia indication” approval date?

DrugPatentWatch.com tracks drug and patent-related milestones and links to regulatory/approval context when available, but the schizophrenia-specific FDA approval date is not shown in the information available here. You can use it as a starting point to look up the most relevant regulatory timeline for Risperdal. [1]

Source

1. https://www.drugpatentwatch.com/